A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy
Diabetes, Obesity and Metabolism · 2024-11 · 26 (11) · 5474-5478
DOI: 10.1111/dom.15875 ↗Kurz gefasst
Leserbrief in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 27.08.2024. Verfasst von Filip K Knop und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Hypoglycemic Agents, Glucagon-Like Peptide-1 Receptor Agonists. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Eli Lilly and Company.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Steno Diabetes Center Copenhagen, Herlev, Denmark.
- Eli Lilly and Company, Indianapolis, Indiana, USA.
ORCID-Profile: Filip K Knop, Shweta Urva, Kieren J Mather, Axel Haupt, Edward John Pratt
Förderung
- Eli Lilly and Company
Zitieren
APA
Knop, F. K., Urva, S., Rettiganti, M., Benson, C. T., Roell, W. C., Mather, K. J., Haupt, A., & Pratt, E. J. (2024). A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy. Diabetes, Obesity and Metabolism, 26(11), 5474-5478. https://doi.org/10.1111/dom.15875
Vancouver
Knop FK, Urva S, Rettiganti M, Benson CT, Roell WC, Mather KJ, et al. A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy. Diabetes, Obesity and Metabolism. 2024;26(11):5474-5478. doi:10.1111/dom.15875
BibTeX
@article{Knop2024,
author = {Knop, Filip K and Urva, Shweta and Rettiganti, Mallikarjuna and Benson, Charles T and Roell, William C and Mather, Kieren J and Haupt, Axel and Pratt, Edward John},
title = {A long‐acting glucose‐dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon‐like peptide‐1 receptor agonist therapy},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {11},
pages = {5474--5478},
doi = {10.1111/dom.15875}
}
EUVIMED